12.1% Average Loss With Semaglutide at 44 Weeks
STEP 7 found semaglutide 2.4 mg led to 12.1% average weight loss at 44 weeks in a predominantly East Asian population, with study context and limits.
At week 44, estimated mean body-weight change was −12.1% with semaglutide 2.4 mg and −3.6% with placebo.
375 adults with overweight or obesity, with or without type 2 diabetes; 72% were enrolled in mainland China, with additional sites in South Korea, Hong Kong, and Brazil; 44-week treatment period. Read the linked peer-reviewed source for the full methodology, findings, and limitations.